BioMed Research International

Malaria Chemotherapy, Eradication and Elimination: Problems, Progress and Prospects


Publishing date
01 Jul 2021
Status
Closed
Submission deadline
12 Mar 2021

1Covenant University, Ota, Nigeria

2Novartis Institutes for Biomedical Research, Basle, Switzerland

3Cheikh Anta Diop University, Dakar, Senegal

This issue is now closed for submissions.

Malaria Chemotherapy, Eradication and Elimination: Problems, Progress and Prospects

This issue is now closed for submissions.

Description

Malaria remains a complex disease affecting over 200 million people and causing over 400,000 deaths globally in 2018. Malaria has existed for many years yet defies multi-targeted control strategies aimed at reducing the disease burden. Eliminating and eradicating malaria has been slowly achieved in some regions, but recently, increasing parasite resistance to therapies has stalled this progress in many other regions, especially in South East Asia and Africa.

Sequencing data and genomic tools provide great insights into malaria parasite genetic diversities and disease dynamics, hence improving knowledge of its elusive strategies. As the development of drug resistance by the parasite limits the efficacy of antimalarial therapies, genomic and genetic tools identifying new phenotypes and the implications for malaria control efforts are important. To achieve global eradication and elimination of malaria, elucidating the evolving mechanisms of malarial parasite biology and antimalarial mechanisms will give further understanding of the disease, which is integral for future control. Translating these findings to effectively eliminate and eradicate malaria globally will go a long way to reduce human suffering.

In this Special Issue, we seek articles investigating new molecular pathways for parasite survival, molecular signatures of artemisinin resistance, mechanisms of antimalarial drugs, and new technologies for malaria control. Submissions relating to genetic modifications of Plasmodium falciparum, Plasmodium vivax, stage dynamics of infections, gametocytaemia, antimalarial chemotherapy, and current topics in malaria control are welcome. This Special Issue aims to attract limited review articles on state-of-the-art molecular tools for mapping transmission trends and antimalarial resistance.

Potential topics include but are not limited to the following:

  • Genomic surveillance for malaria elimination and eradication
  • New mechanisms of parasite resistance to antimalarial drugs
  • Vector resistance and control
  • Genetic diversities and heterogeneity of infections
  • Malaria vaccine efficacy
  • Molecular mechanisms of malaria pathogenesis
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.